154-17-6 , 2-脱氧-D-葡萄糖,
2-Deoxy-D-Glucose,
CAS:154-17-6
C6H12O5 / 164.16
MFCD00151328
2-deoxy-D-Glucose is a glucose antimetabolite and an inhibitor of glycolysis. It inhibits hexokinase, the enzyme that converts glucose to glucose-6-phosphate, as well as phosphoglucose isomerase, the enzyme that converts glucose-6-phosphate to fructose-6-phosphate. 2-deoxy-D-glucose (16 mM) induces apoptosis in SK-BR-3 cells, as well as inhibits the growth of 143B osteosarcoma cells cultured under hypoxic conditions when used at a concentration of 2 mg/ml. In vivo, 2-deoxy-D-glucose (500 mg/kg) reduces tumor growth in 143B osteosarcoma and MV522 non-small cell lung cancer mouse xenograft models when used alone or in combination with doxorubicin or paclitaxel.
2-Deoxyglucose, also known as 2-deoxy-D-mannose or D-2DGLC, belongs to the class of organic compounds known as fatty alcohols. These are aliphatic alcohols consisting of a chain of a least six carbon atoms. 2-Deoxyglucose has been primarily detected in urine. Within the cell, 2-deoxyglucose is primarily located in the cytoplasm. 2-Deoxyglucose exists in all eukaryotes, ranging from yeast to humans.
2-deoxyglucose is predominantly used as a diagnostic agent in its radiolabelled form (fluorine-18 is used as the radiolabel). By using positron emission tomography (PET), radiolabelled 2-deoxyglucose can determine glucose metabolism, which is altered in diseases such as cardiovascular disease, tumors, and Alzheimer's disease. Therapeutically, 2-deoxyglucose is an investigational drug that is being studied as an anticancer and antiviral agent. Concerning the former, 2- deoxyglucose was used as an adjunct to chemotherapy and radiotherapy in the treatment of solid tumors (lung, breast, pancreas, head, neck, and gastric tumors). The exact mechanisms of action of 2-deoxyglucose is still being investigated, but it is known that in hypoxic cancer cells, 2-deoxyglucose is a glycolysis inhibitor that prevents ATP production and, ultimately, cell survival. With respect to antiviral therapy, 2-deoxyglucose was shown to be effective against herpes simplex virus by affecting the virus' ability to penetrate cells. As an experimental drug, 2-deoxyglucose was demonstrated to work as an anticonvulsant in temporal lobe epilepsy. In this condition, 2-deoxyglucose represses the expression of certain proteins that are at high levels after a seizure. Although there are several possible therapeutic indications for 2-deoxyglucose, presently there is no approved indication for 2-deoxyglucose as a therapeutic agent.
2-Deoxy-D-arabino-hexose. An antimetabolite of glucose with antiviral activity.
Title: 2-Deoxy-D-glucose
CAS Registry Number: 154-17-6
CAS Name: 2-Deoxy-D-arabino-hexose
Additional Names: D-arabino-2-desoxyhexose; 2-deoxyglucose; 2-DG
Manufacturers' Codes: Ba-2758
Molecular Formula: C6H12O5
Molecular Weight: 164.16
Percent Composition: C 43.90%, H 7.37%, O 48.73%
Literature References: Antimetabolite of glucose, q.v., with antiviral activity. Synthesis: M. Bergmann et al., Ber. 55, 158 (1922); 56, 1052 (1923); J. C. Sowden, H. O. L. Fischer, J. Am. Chem. Soc. 69, 1048 (1947); H. R. Bolliger, Helv. Chim. Acta 34, 989 (1954); H. R. Bolliger, M. D. Schmid, ibid. 1597, 1671; H. R. Bolliger, "2-Deoxy-D-arabino-hexose (2-Deoxy-D-glucose)" in Methods in Carbohydrate Chemistry vol. I, R. L. Whistler, M. L. Wolfrom, Eds. (Academic Press, New York, 1962) pp 186-189. Inhibition of influenza virus multiplication: E. D. Kilbourne, Nature 183, 271 (1959). Effects on herpes simplex virus: R. J. Courtney et al., Virology 52, 447 (1973). Mechanism of action studies: M. R. Steiner et al., Biochem. Biophys. Res. Commun. 61, 745 (1974); E. K. Ray et al., Virology 58, 118 (1978). Use in human genital herpes infections: H. A. Blough, R. L. Giuntoli, J. Am. Med. Assoc. 241, 2798 (1979); L. Corey, K. K. Holmes, ibid. 243, 29 (1980). Effect vs respiratory syncytial viral infections in calves: S. B. Mohanty et al., Am. J. Vet. Res. 42, 336 (1981).
Properties: Cryst from acetone or butanone, mp 142-144°. [a]D17.5 +38.3° (35 min) ®+45.9° (c = 0.52 in water); +22.8° (24 hrs) ® +80.8° (c = 0.57 in pyridine).
Melting point: mp 142-144°
Optical Rotation: [a]D17.5 +38.3° (35 min) ®+45.9° (c = 0.52 in water); +22.8° (24 hrs) ® +80.8° (c = 0.57 in pyridine)
Derivative Type: a-Form
Properties: Cryst from isopropanol, mp 134-136°. [a]D26 +156° ® +103° (c = 0.9 in pyridine).
Melting point: mp 134-136°
Optical Rotation: [a]D26 +156° ® +103° (c = 0.9 in pyridine)
Use: Exptlly as an antiviral agent.
CAS Number | 154-17-6 |
Product Name | Deoxyglucose |
IUPAC Name | (3R,4S,5R)-3,4,5,6-tetrahydroxyhexanal |
Molecular Formula | C6H12O5 |
Molecular Weight | 164.16 g/mol |
InChI | InChI=1S/C6H12O5/c7-2-1-4(9)6(11)5(10)3-8/h2,4-6,8-11H,1,3H2/t4-,5-,6+/m1/s1 |
InChI Key | VRYALKFFQXWPIH-PBXRRBTRSA-N |
SMILES | C(C=O)C(C(C(CO)O)O)O |
Solubility | Soluble in DMSO |
Synonyms | 2 Deoxy D glucose, 2 Deoxyglucose, 2 Desoxy D glucose, 2-Deoxy-D-glucose, 2-Deoxyglucose, 2-Desoxy-D-glucose, Deoxyglucose |
Canonical SMILES | C(C=O)C(C(C(CO)O)O)O |
Isomeric SMILES | C(C=O)[C@@H]([C@H]([C@H](CO)O)O)O |
CAS No: 154-17-6 MDL No: MFCD00151328 Chemical Formula: C6H12O5 Molecular Weight: 164.16 | In Stock, 国产现货高纯,白色结晶粉末. |
COA:
Name: 2-Deoxy-D-Glucose CAS: 154-17-6 M.F.: C6H12O5
M.W.: 164.16 Batch No: 20120203 Quantity: 26.22kg
Items | Standards | Results |
Appearance | White crystalline powder | Positive |
Solubility | Readily soluble in water and insoluble in ether | Positive |
NMR and MS | Should comply | Complies |
Identification | IR and TLC | Positive |
M.P. | 145℃ ~147℃ | 145℃ ~147℃ |
[a]D [c=1 inH2O]. | +44o ~ +47o | +45.2o |
Loss Weight On Dryness | Max. 1% | Complies |
Heavy Metal | Max. 20ppm | Complies |
TLC (15%H2SO4-C2H5OH) | One spot | Complies |
Assay (HPLC) | Min. 98% | 98.6% |
References:
1. Thakkar NS, Potten CS, Cancer Res. 1993, 53, 2057
联系人:邢经理
手机: 18310328607 , 13621067991,13552979007
电话:86+10-61274189
邮箱:chemsynlab@163.com, zhangchao@chemsynlab.com
地址: 北京市大兴区金苑路26号1幢4层411室